DB14771InvestigationalSmall molecule
Polyacrylamide (crosslinked; 2 mole percent bisacrylamide) is under investigation in clinical trial NCT00629083 (Bulking Agents for the Treatment of Stress Urinary Incontinence in Females).
- Also known as
- BULKAMID
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of April 02, 2025
Which companies are running trials of Polyacrylamide (crosslinked; 2 mole percent bisacrylamide), in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account